Erratum to "Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach"

Cynthia D J Kusters¹, Kimberly C Paul², Aline Duarte Folle³, Adrienne M Keener^{2

4}, Jeff M Bronstein^{2

5}, Lars Bertram^{6

7}, Johnni Hansen⁸, Steve Horvath^{1

9}, Janet S Sinsheimer^{1

9

10}, Christina M Lill^{11

12}, Beate R Ritz^{2

3

13}

Affiliations

¹ Department of Human Genetics, David Geffen School of Medicine, Los Angeles, California, USA.
² Department of Neurology, David Geffen School of Medicine, Los Angeles, California, USA.
³ Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
⁴ Parkinson's Disease Research, Education, and Clinical Center, Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, California, USA.
⁵ Brain Research Institute, University of California, Los Angeles, California, USA.
⁶ Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
⁷ Department of Psychology, Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway.
⁸ Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
⁹ Department of Biostatistics, School of Public Health, University of California, Los Angeles, California, USA.
¹⁰ Department of Computational Medicine, David Geffen School of Medicine, Los Angeles, California, USA.
¹¹ Translational Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
¹² Ageing Epidemiology Research Unit, School of Public Health, Imperial College, London, UK.
¹³ Department of Environmental Health, UCLA Fielding School of Public Health, Los Angeles, California, USA.

Published Erratum

Cynthia D J Kusters et al. Mov Disord. 2022 Jun.

. 2022 Jun;37(6):1282-1283.

doi: 10.1002/mds.28974. Epub 2022 Mar 4.

¹ Department of Human Genetics, David Geffen School of Medicine, Los Angeles, California, USA.
² Department of Neurology, David Geffen School of Medicine, Los Angeles, California, USA.
³ Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
⁴ Parkinson's Disease Research, Education, and Clinical Center, Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, California, USA.
⁵ Brain Research Institute, University of California, Los Angeles, California, USA.
⁶ Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
⁷ Department of Psychology, Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway.
⁸ Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
⁹ Department of Biostatistics, School of Public Health, University of California, Los Angeles, California, USA.
¹⁰ Department of Computational Medicine, David Geffen School of Medicine, Los Angeles, California, USA.
¹¹ Translational Epidemiology Group, Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
¹² Ageing Epidemiology Research Unit, School of Public Health, Imperial College, London, UK.
¹³ Department of Environmental Health, UCLA Fielding School of Public Health, Los Angeles, California, USA.

No abstract available

Keywords: Mendelian randomization; Parkinson's disease; menopausal age.

Figures

Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
Kusters CDJ, Paul KC, Duarte Folle A, Keener AM, Bronstein JM, Bertram L, Hansen J, Horvath S, Sinsheimer JS, Lill CM, Ritz BR. Kusters CDJ, et al. Mov Disord. 2021 Oct;36(10):2264-2272. doi: 10.1002/mds.28760. Epub 2021 Aug 23. Mov Disord. 2021. PMID: 34426982 Free PMC article.

1. Kusters CDJ, Paul KCK, Duarte Folle A, et al. Increased menopausal age reduces the risk of Parkinson’s disease: a Mendelian randomization approach. Mov Disord 2021;36:2264–2272. - PMC - PubMed
1. Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain 2013;136:2419–2431. - PMC - PubMed
1. Nalls MA, Escott-Price V, Williams NM, et al. Genetic risk and age in Parkinson’s disease: continuum not stratum. Mov Disord 2015;30: 850–854. - PMC - PubMed
1. Blauwendraat C, Heilbron K, Vallerga CL, et al. Parkinson disease age at onset GWAS: defining heritability, genetic loci and α-synuclein mechanisms. Mov Disord 2019;34:866. - PMC - PubMed
1. Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson’s disease. Ann Neurol 2003;54:507–513. - PubMed